The Efficiency of Intravitreal Bevacizumab for the Treatment (Primary) of Diabetic Macular Oedema - 03 Month Anatomic and Visual Acuity Response. In a Selected Population in the Northern Territory, Australia. A Hospital Based Study

Siriwardana, P.S. (D 3714)

dc.contributor.author	Siriwardana, P.S. (D 3714)
dc.date.accessioned	2025-05-16T09:33:23Z
dc.date.available	2025-05-16T09:33:23Z
dc.date.issued	2012
dc.identifier.uri	http://librepository.pgim.cmb.ac.lk/handle/1/6616
dc.language.iso	en	en_US
dc.publisher	Postgraduate Institute of Medicine	en_US
dc.subject	Efficiency of Intravitreal Bevacizumab	en_US
dc.subject	Treatment (Primary) of Diabetic Macular Oedema	en_US
dc.subject	Anatomic and Visual Acuity Response	en_US
dc.title	The Efficiency of Intravitreal Bevacizumab for the Treatment (Primary) of Diabetic Macular Oedema - 03 Month Anatomic and Visual Acuity Response. In a Selected Population in the Northern Territory, Australia. A Hospital Based Study	en_US
dc.type	Thesis	en_US